论文部分内容阅读
以科学的名义让时日不多的癌症患者重新忍受一次侵入式的活检手术是否值得?当Jack(化名)最后一次复查的时候,医生告诉他:先前让他肿瘤缩小的药已经失效,肿瘤卷土重来,黑素瘤疯狂生长使得他的腿肿得厉害。这名40多岁的计算机顾问已时日不多。随即,Jack的医生,美国加州大学洛杉矶分校肿瘤中心的Roger Lo打电话给他,询问是否可以获得他的肿瘤标本以供研究。虽然Jack的有生之年将基本没有可能受益于该研究;而且,Jack需要
Is it worthwhile to endorse a less-invasive cancer patient in the name of science for an invasive biopsy? The last time Jack reviewed, the doctor told him that the drug that had previously made his tumor shrink had failed and that the tumor came back The crazy growth of melanoma made his legs swollen badly. This 40-year-old computer consultant has been running out of time. Immediately, Jack’s doctor, Roger Lo, of the University of California, Los Angeles Cancer Center, called him and asked if his tumor specimens were available for research. Although Jack’s life will be basically impossible to benefit from the study; and, Jack needs